The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
The Journal of Psychopharmacology is truly international in scope and readership. This is reflected by its editorial board which has brought together the very best of clinical and preclinical psychopharmacology from around the world.
Published monthly, the Journal of Psychopharmacology provides readers with an extensive array of regular features, including:
/// Original Research - original scientific papers addressing preclinical and clinical aspects of psychopharmacology
/// Critique - papers on topics of general interest and importance written by experts, commentaries by other authorities and their rejoinders provide the reader with a rounded understanding of the issues involved
/// Perspectives - pithy, thought-provoking, short and focused reviews
/// Letters - facilitating an ongoing dialogue on key issues of psychopharmacology, the letters address issues raised by published articles, or report significant new findings that merit rapid dissemination